Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity

Journal of Lipid Research

Volumn 55, Issue 10, 2014, Pages 2124-2136

  Zha, Weibin ^a   Edin, Matthew L ^c   Vendrov, Kimberly C ^a   Schuck, Robert N ^a   Lih, Fred B ^c   Jat, Jawahar Lal ^d   Bradbury, J Alyce ^c   DeGraff, Laura M ^c   Hua, Kunjie ^b   Tomer, Kenneth B ^c   Falck, John R ^d   Zeldin, Darryl C ^c   Lee, Craig R ^a  

^a University of North Carolina   (United States)

^b IL   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adipose tissue; Arachidonic acid; Eicosanoids; High fat diet; Metabolomics; Soluble epoxide hydrolase

Indexed keywords

CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; MESSENGER RNA; FAT INTAKE; ICOSANOID;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE INDUCTION; GLUCOSE INTOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OBESITY; PROADIPOCYTE; PROTEIN ANALYSIS; PROTEIN FUNCTION; TISSUE EXPANSION; WEIGHT GAIN; 3T3 CELL LINE; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; FAT INTAKE; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

3T3-L1 CELLS; ADIPOGENESIS; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DIETARY FATS; EICOSANOIDS; GENE EXPRESSION REGULATION; GLUCOSE INTOLERANCE; MICE; MICE, KNOCKOUT; OBESITY;

EID: 84907484279     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M053199     Document Type: Article

References (49)

1. Flegal, K. M., M. D. Carroll, B. K. Kit, and C. L. Ogden. 2012. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 307: 491-497.
2. Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman. 2000 Transcriptional regulation of adipogenesis. Genes Dev. 14: 1293-1307.
3. MacDougald, O. A., and M. D. Lane. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64: 345-373.
4. Odegaard, J. I., and A. Chawla. 2013. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science. 339: 172-177.
5. Sun, K., C. M. Kusminski, and P. E. Scherer. 2011. Adipose tissue remodeling and obesity. J. Clin. Invest. 121: 2094-2101.
6. Zeldin, D. C. 2001. Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276: 36059-36062.
7. Imig, J. D. 2012. Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol. Rev. 92: 101-130.
8. Deng, Y., K. N. Theken, and C. R. Lee. 2010. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J. Mol. Cell. Cardiol. 48: 331-341.
9. Sodhi, K., N. Puri, K. Inoue, J. R. Falck, M. L. Schwartzman, and N. G. Abraham. 2012. EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels. Prostaglandins Other Lipid Mediat. 98: 133-142.
10. Bettaieb, A., N. Nagata, D. AbouBechara, S. Chahed, C. Morisseau, B. D. Hammock, and F. G. Haj. 2013. Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue. J. Biol. Chem. 288: 14189-14199.
11. Luria, A., A. Bettaieb, Y. Xi, G. J. Shieh, H. C. Liu, H. Inoue, H. J. Tsai, J. D. Imig, F. G. Haj, and B. D. Hammock. 2011. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc. Natl. Acad. Sci. USA. 108: 9038-9043.
12. Xu, X., C. X. Zhao, L. Wang, L. Tu, X. Fang, C. Zheng, M. L. Edin, D. C. Zeldin, and D. W. Wang. 2010. Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. Diabetes. 59: 997-1005.
13. Imig, J. D., A. Elmarakby, K. Nithipatikom, S. Wei, J. H. Capdevila, V. R. Tuniki, B. Sangras, S. Anjaiah, V. L. Manthati, D. Sudarshan Reddy, et al. 2010. Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions. Front. Physiol. 1: 157.
14. Khan, M. A., J. Liu, G. Kumar, S. X. Skapek, J. R. Falck, and J. D. Imig. 2013. Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity. FASEB J. 27: 2946-2956.
15. Wang, H., Y. Zhao, J. A. Bradbury, J. P. Graves, J. Foley, J. A. Blaisdell, J. A. Goldstein, and D. C. Zeldin. 2004. Cloning, expression, and characterization of three new mouse cytochrome p450 enzymes and partial characterization of their fatty acid oxidation activities. Mol. Pharmacol. 65: 1148-1158.
16. Qu, W., J. A. Bradbury, C. C. Tsao, R. Maronpot, G. J. Harry, C. E. Parker, L. S. Davis, M. D. Breyer, M. P. Waalkes, J. R. Falck, et al. 2001. Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain. J. Biol. Chem. 276: 25467-25479.
17. Zha, B. S., X. Wan, X. Zhang, W. Zha, J. Zhou, M. Wabitsch, G. Wang, V. Lyall, P. B. Hylemon, and H. Zhou. 2013. HIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytes. PLoS ONE. 8: e59514.
18. Sinal, C. J., M. Miyata, M. Tohkin, K. Nagata, J. R. Bend, and F. J. Gonzalez. 2000. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J. Biol. Chem. 275: 40504-40510.
19. Deng, Y., M. L. Edin, K. N. Theken, R. N. Schuck, G. P. Flake, M. A. Kannon, L. M. DeGraff, F. B. Lih, J. Foley, J. A. Bradbury, et al. 2011 Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice. FASEB J. 25: 703-713.
20. Edin, M. L., Z. Wang, J. A. Bradbury, J. P. Graves, F. B. Lih, L. M. DeGraff, J. F. Foley, R. Torphy, O. K. Ronnekleiv, K. B. Tomer, et al. 2011. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. FASEB J. 25: 3436-3447.
21. Theken, K. N., Y. Deng, R. N. Schuck, A. Oni-Orisan, T. M. Miller, M. A. Kannon, S. M. Poloyac, and C. R. Lee. 2012. Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism. Am. J. Physiol. Endocrinol. Metab. 302: E500-E509.
22. Theken, K. N., Y. Deng, M. A. Kannon, T. M. Miller, S. M. Poloyac, and C. R. Lee. 2011. Activation of the acute inflammatory response alters cytochrome p450 expression and eicosanoid metabolism. Drug Metab. Dispos. 39: 22-29.
23. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25: 402-408.
24. Zha, W., G. Liang, J. Xiao, E. J. Studer, P. B. Hylemon, W. M. Pandak, Jr., G. Wang, X. Li, and H. Zhou. 2010. Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages. PLoS ONE. 5: e9069.
25. Morisseau, C., and B. D. Hammock. 2007. Measurement of soluble epoxide hydrolase (sEH) activity. Curr. Protoc. Toxicol. 33: 4.23.1-4.23.18.
26. Theken, K. N., R. N. Schuck, M. L. Edin, B. Tran, K. Ellis, A. Bass, F. B. Lih, K. B. Tomer, S. M. Poloyac, M. C. Wu, et al. 2012. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. Atherosclerosis. 222: 530-536.
27. Osman, O. S., J. L. Selway, M. A. Kepczynska, C. J. Stocker, J. F. O'Dowd, M. A. Cawthorne, J. R. Arch, S. Jassim, and K. Langlands. 2013 A novel automated image analysis method for accurate adipocyte quantification. Adipocyte. 2: 160-164.
28. Mathes, W. F., D. L. Aylor, D. R. Miller, G. A. Churchill, E. J. Chesler, F. P. de Villena, D. W. Threadgill, and D. Pomp. 2011. Architecture of energy balance traits in emerging lines of the Collaborative Cross. Am. J. Physiol. Endocrinol. Metab. 300: E1124-E1134.
29. Ayala, J. E., V. T. Samuel, G. J. Morton, S. Obici, C. M. Croniger, G. I. Shulman, D. H. Wasserman, and O. P. McGuinness. 2010. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis. Model. Mech. 3: 525-534.
30. Xia, J., R. Mandal, I. V. Sinelnikov, D. Broadhurst, and D. S. Wishart. 2012 MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 40: W127-W133.
31. Zhao, X., A. Dey, O. P. Romanko, D. W. Stepp, M. H. Wang, Y. Zhou, L. Jin, J. S. Pollock, R. C. Webb, and J. D. Imig. 2005. Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288: R188-R196.
32. Mothe-Satney, I., C. Filloux, H. Amghar, C. Pons, V. Bourlier, J. Galitzky, P. A. Grimaldi, C. C. Feral, A. Bouloumie, E. Van Obberghen, et al. 2012. Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes. 61: 2311-2319.
33. Ghoshal, S., D. B. Trivedi, G. A. Graf, and C. D. Loftin. 2011. Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice. J. Biol. Chem. 286: 889-898.
34. Vanella, L., D. H. Kim, K. Sodhi, I. Barbagallo, A. P. Burgess, J. R. Falck, M. L. Schwartzman, and N. G. Abraham. 2011. Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes. Prostaglandins Other Lipid Mediat. 96: 54-62.
35. De Taeye, B. M., C. Morisseau, J. Coyle, J. W. Covington, A. Luria, J. Yang, S. B. Murphy, D. B. Friedman, B. B. Hammock, and D. E. Vaughan. 2010. Expression and regulation of soluble epoxide hydrolase in adipose tissue. Obesity (Silver Spring). 18: 489-498.
36. Kim, D. H., L. Vanella, K. Inoue, A. Burgess, K. Gotlinger, V. L. Manthati, S. R. Koduru, D. C. Zeldin, J. R. Falck, M. L. Schwartzman, et al. 2010. Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARγ. Stem Cells Dev. 19: 1863-1873.
37. Burgess, A. P., L. Vanella, L. Bellner, K. Gotlinger, J. R. Falck, N. G. Abraham, M. L. Schwartzman, and A. Kappas. 2012. Heme oxygenase (HO-1) rescue of adipocyte dysfunction in HO-2 deficient mice via recruitment of epoxyeicosatrienoic acids (EETs) and adiponectin. Cell. Physiol. Biochem. 29: 99-110.
38. Madsen, L., R. K. Petersen, M. B. Sorensen, C. Jorgensen, P. Hallenborg, L. Pridal, J. Fleckner, E. Z. Amri, P. Krieg, G. Furstenberger, et al. 2003. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process. Biochem. J. 375: 539-549.
39. Wang, M., J. J. Wang, J. Li, K. Park, X. Qian, J. X. Ma, and S. X. Zhang. 2009. Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes. Am. J. Physiol. Endocrinol. Metab. 297: E1378-E1387.
40. Li, F., D. Wang, Y. Zhou, B. Zhou, Y. Yang, H. Chen, and J. Song. 2008 Protein kinase A suppresses the differentiation of 3T3-L1 preadipocytes. Cell Res. 18: 311-323.
41. Dagon, Y., Y. Avraham, and E. M. Berry. 2006. AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes. Biochem. Biophys. Res. Commun. 340: 43-47.
42. Yang, S., L. Lin, J. X. Chen, C. R. Lee, J. M. Seubert, Y. Wang, H. Wang, Z. R. Chao, D. D. Tao, J. P. Gong, et al. 2007. Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways. Am. J. Physiol. Heart Circ. Physiol. 293: H142-H151.
43. Carroll, M. A., A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff. 2006. Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway. Am. J. Physiol. Renal Physiol. 291: F155-F161.
44. Cannon, B., and J. Nedergaard. 2004. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84: 277-359.
45. Spiegelman, B. M. 2013. Banting Lecture 2012: Regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes. 62: 1774-1782.
46. Wang, Q. A., C. Tao, R. K. Gupta, and P. E. Scherer. 2013. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat. Med. 19: 1338-1344.
47. Yamauchi, T., H. Waki, J. Kamon, K. Murakami, K. Motojima, K. Komeda, H. Miki, N. Kubota, Y. Terauchi, A. Tsuchida, et al. 2001. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Invest. 108: 1001-1013.
48. Rieusset, J., F. Touri, L. Michalik, P. Escher, B. Desvergne, E. Niesor, and W. Wahli. 2002. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. Mol. Endocrinol. 16: 2628-2644.
49. Lee, Y. S., P. Li, J. Y. Huh, I. J. Hwang, M. Lu, J. I. Kim, M. Ham, S. Talukdar, A. Chen, W. J. Lu, et al. 2011. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes. 60: 2474-2483.